Goldenberg, Simon D, Dodgson, Andrew R, Barlow, Gavin et al. (11 more authors) (2022) Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK:A Retrospective, Observational Study (CARBAR UK). Advances in therapy. pp. 3602-3615. ISSN 1865-8652
Abstract
INTRODUCTION: Antimicrobial resistance is an urgent medical challenge. In this two-part study, we investigated the epidemiology and management of carbapenem non-susceptible (Carb-NS) Gram-negative bacteria (GNB) in the UK. METHODS: We conducted a retrospective review of data from UK hospitals (ten in part 1, nine in part 2). In part 1, epidemiological data were collected from patients hospitalised between April 2017 and March 2018 with any laboratory detection of Carb-NS GNB, encompassing both colonisation and infection. In part 2, diagnosis and management pathways in a randomly selected population of adults from part 1 with confirmed Carb-NS GNB infection were assessed. Data were obtained from a detailed medical chart review for ≥ 3 months from index (collection date of first positive Carb-NS GNB sample). RESULTS: Of 42,340 GNB isolates from 36,098 patients colonised/infected with GNB in part 1, 7% were Carb-NS. In 157 patients included in part 2, 234 GNB index samples were collected, of which 197 (82%) were Carb-NS (median number of Carb-NS pathogens per patient, 1; range 1-3). The most frequent Carb-NS isolates were Pseudomonas aeruginosa (36%), Stenotrophomonas maltophilia (29%) and Klebsiella pneumoniae (10%). Median length of hospitalisation was 34 days. Median time from index to appropriate therapy was 3 days, with empirical therapy initiated a median of 1 day before index. Carb-NS infection was believed to contribute to 21 (28%) of 76 deaths during the study. CONCLUSIONS: This study highlights the high incidence of Carb-NS GNB colonisation and infection in the UK and the need for improved management of patients with Carb-NS GNB infection.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2022. The Author(s). |
Keywords: | Adult,Anti-Bacterial Agents/therapeutic use,Carbapenems/therapeutic use,Gram-Negative Bacteria,Gram-Negative Bacterial Infections/drug therapy,Humans,Retrospective Studies,United Kingdom/epidemiology |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Sciences (York) > Hull York Medical School (York) |
Depositing User: | Pure (York) |
Date Deposited: | 02 Oct 2023 10:40 |
Last Modified: | 16 Oct 2024 19:28 |
Published Version: | https://doi.org/10.1007/s12325-022-02177-3 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1007/s12325-022-02177-3 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:203864 |